{"id":7301,"date":"2022-04-05T09:18:37","date_gmt":"2022-04-05T17:18:37","guid":{"rendered":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7301"},"modified":"2022-06-04T18:34:35","modified_gmt":"2022-06-05T02:34:35","slug":"tezspire-tezepelumab-monoclonal-antibody-for-the-treatment-of-severe-asthma","status":"publish","type":"post","link":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7301","title":{"rendered":"Tezspire (Tezepelumab), Monoclonal Antibody for the Treatment of Severe Asthma"},"content":{"rendered":"

Drug Info: <\/a><\/strong>ApoThera Drug Disease Clinical Support App<\/a><\/strong><\/em><\/p>\n

Severe Asthma<\/b><\/div>\n
– 210 mg SC every 4 weeks<\/div>\n
– Add-on maintenance treatment of severe asthma<\/div>\n
\n
Missed Dose<\/i><\/b><\/div>\n
– Administer dose as soon as possible<\/div>\n
– Thereafter, resume dosing on the usual day of administration<\/div>\n
– If the next dose is already due, then administer as planned<\/div>\n<\/div>\n
Limitations of Use<\/i><\/b><\/div>\n
– Not indicated for the relief of acute bronchospasm or status asthmaticus<\/div>\n
\n
Administration<\/b><\/div>\n
– Inject SC into upper arm, thigh, or abdomen, except for the 2 inches (5 cm) around navel<\/div>\n
– Avoid injecting into areas where skin is tender, bruised, erythematous, or hardened<\/div>\n
– Rotate injection site with each administration<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Drug Info: ApoThera Drug Disease Clinical Support App Severe Asthma – 210 mg SC every 4 weeks – Add-on maintenance treatment of severe asthma Missed Dose – Administer dose as…<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[16],"tags":[282,283,278,264,297,266,279,281,280],"class_list":["post-7301","post","type-post","status-publish","format-standard","hentry","category-blog","tag-amgen","tag-apothera","tag-asthma","tag-biotech","tag-clinical-decision-support","tag-drug-information","tag-monoclonal-antibody","tag-tezepelumab","tag-tezspire"],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":7324,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7324","url_meta":{"origin":7301,"position":0},"title":"Monoclonal Antibodies for Treating Severe Asthma","date":"April 5, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App ApoThera Specialty Medications, Monoclonal Antibodies, Available for Treating Severe Asthma: - Cinqair (Reslizumab) - Dupixent (Dupilumab) - Fasenra (Benralizumab) - Tezspire (Tezepelumab) \u00a0","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7530,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7530","url_meta":{"origin":7301,"position":1},"title":"Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and Evusheld (Tixagevimab-Cilgavimab)","date":"April 8, 2022","format":"image","excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Drug Info: ApoThera Drug Disease Clinical Support App Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and COVID-19 Polyclonal Antibody Evusheld (Tixagevimab-Cilgavimab) Available on ApoThera Clinical Decision Support Mobile \u00a0","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2022\/04\/COVID.19.Viral_.Replication.and_.Symptom.Onset_.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":7374,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7374","url_meta":{"origin":7301,"position":2},"title":"FDA Pulls Authorization for GSK-Vir’s COVID Therapy, Sotrovimab, as BA.2 Cases Rise","date":"April 6, 2022","format":false,"excerpt":"The U.S. health regulator said on Tuesday GlaxoSmithKline (GSK.L) and Vir Biotechnology's (VIR.O) antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country. Drug Information for COVID-19 Monoclonal Antibody (Bebtelovimab) and COVID-19 Polyclonal\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":10098,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10098","url_meta":{"origin":7301,"position":3},"title":"In Stock: Mounjaro 2.5mg Pre-Filled Pen SC Injection (Tirzepatide 2.5mg Pre-Filled Pen SC Injection)","date":"April 3, 2023","format":false,"excerpt":"\u2013 Prescription Required \u2013 Free Next Day Delivery to Anywhere in CA and NY \u2013 Free Same Day Delivery within 50-Mile Radius of ApoThera \u2013 Concierge Pharmacy; Do NOT Accept Insurance \u2013 Annual Concierge Pharmacy Membership Fee: $300\/year \u2013 Accept Credit Cards, Apple Pay and Zelle \u2013 Do NOT\u00a0accept\u00a0manufacturer coupons\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2023\/04\/mounjaro.2.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":10093,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10093","url_meta":{"origin":7301,"position":4},"title":"In Stock: Ozempic (Semaglutide) 2mg Dose Pen SC Injector","date":"April 2, 2023","format":false,"excerpt":"In Stock: Ozempic 2mg Dose Pen SC Injector (Click Here) Diabetes Mellitus, Type 2 Initial Dose \u2013 0.25 mg SC weekly for 4 weeks Maintenance Dose \u2013 Increase the dosage to 0.5 mg SC weekly \u2013 If glycemic control not achieved after at least 4 weeks on 0.5-mg dose, can\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7291,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7291","url_meta":{"origin":7301,"position":5},"title":"Opdualag (Nivolumab-Relatlimab), for the Treatment of Melanoma","date":"April 5, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Melanoma Unresectable or Metastatic - 480mg\/160mg IV every 4 weeks - Continue until disease progression or unacceptable toxicity occurs Infusion-related Reactions Grade 1 or 2 - Interrupt or slow infusion rate Grade 3 or 4 - Permanently discontinue Females of Reproductive Potential\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7301"}],"version-history":[{"count":4,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7301\/revisions"}],"predecessor-version":[{"id":7998,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7301\/revisions\/7998"}],"wp:attachment":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}